Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 78

1.

HDL cholesterol efflux capacity and cholesteryl ester transfer are associated with body mass, but are not changed by diet-induced weight loss: A randomized trial in abdominally obese men.

Talbot CPJ, Plat J, Joris PJ, Konings M, Kusters YHAM, Schalkwijk CG, Ritsch A, Mensink RP.

Atherosclerosis. 2018 Jul;274:23-28. doi: 10.1016/j.atherosclerosis.2018.04.029. Epub 2018 Apr 28.

PMID:
29747087
2.

Expression, Purification, and Biochemical Characterization of Human Afamin.

Altamirano A, Naschberger A, Fürnrohr BG, Saldova R, Struwe WB, Jennings PM, Millán Martín S, Malic S, Plangger I, Lechner S, Pisano R, Peretti N, Linke B, Aguiar MM, Fresser F, Ritsch A, Lenac Rovis T, Goode C, Rudd PM, Scheffzek K, Rupp B, Dieplinger H.

J Proteome Res. 2018 Mar 2;17(3):1269-1277. doi: 10.1021/acs.jproteome.7b00867. Epub 2018 Feb 20.

PMID:
29441788
3.

Determinants of cholesterol efflux capacity in humans.

Talbot CPJ, Plat J, Ritsch A, Mensink RP.

Prog Lipid Res. 2018 Jan;69:21-32. doi: 10.1016/j.plipres.2017.12.001. Epub 2017 Dec 18. Review.

PMID:
29269048
4.

Knockout of Apolipoprotein E in rabbit promotes premature intervertebral disc degeneration: A new in vivo model for therapeutic approaches of spinal disc disorders.

Beierfuß A, Dietrich H, Kremser C, Hunjadi M, Ritsch A, Rülicke T, Thomé C, Mern DS.

PLoS One. 2017 Nov 3;12(11):e0187564. doi: 10.1371/journal.pone.0187564. eCollection 2017.

5.

High-Density Lipoprotein Subclasses, Coronary Artery Disease, and Cardiovascular Mortality.

Silbernagel G, Pagel P, Pfahlert V, Genser B, Scharnagl H, Kleber ME, Delgado G, Ohrui H, Ritsch A, Grammer TB, Koenig W, März W.

Clin Chem. 2017 Dec;63(12):1886-1896. doi: 10.1373/clinchem.2017.275636. Epub 2017 Oct 11.

PMID:
29021325
6.

Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.

Zewinger S, Kleber ME, Rohrer L, Lehmann M, Triem S, Jennings RT, Petrakis I, Dressel A, Lepper PM, Scharnagl H, Ritsch A, Thorand B, Heier M, Meisinger C, de Las Heras Gala T, Koenig W, Wagenpfeil S, Schwedhelm E, Böger RH, Laufs U, von Eckardstein A, Landmesser U, Lüscher TF, Fliser D, März W, Meinitzer A, Speer T.

Eur Heart J. 2017 May 21;38(20):1597-1607. doi: 10.1093/eurheartj/ehx118.

PMID:
28379378
7.

HDL cholesterol: reappraisal of its clinical relevance.

März W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein A, Landmesser U, Laufs U.

Clin Res Cardiol. 2017 Sep;106(9):663-675. doi: 10.1007/s00392-017-1106-1. Epub 2017 Mar 24. Review.

8.

[Clinical importance of HDL cholesterol].

März W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein A, Landmesser U, Laufs U.

Herz. 2017 Feb;42(1):58-66. doi: 10.1007/s00059-016-4499-0. Epub 2016 Nov 14. Review. German.

PMID:
27844137
9.

Research update for articles published in EJCI in 2014.

Agra RM, Al-Daghri NM, Badimon L, Bodi V, Carbone F, Chen M, Cubedo J, Dullaart RP, Eiras S, García-Monzón C, Gary T, Gnoni A, González-Rodríguez Á, Gremmel T, Hafner F, Hakala T, Huang B, Ickmans K, Irace C, Kholová I, Kimer N, Kytö V, März W, Miazgowski T, Møller S, Montecucco F, Niccoli G, Nijs J, Ozben S, Ozben T, Papassotiriou I, Papastamataki M, Reina-Couto M, Rios-Navarro C, Ritsch A, Sabico S, Seetho IW, Severino A, Sipilä J, Sousa T, Taszarek A, Taurino F, Tietge UJ, Tripolino C, Verloop W, Voskuil M, Wilding JP.

Eur J Clin Invest. 2016 Oct;46(10):880-94. doi: 10.1111/eci.12671. No abstract available.

PMID:
27571922
10.

Leoligin, the major lignan from Edelweiss, inhibits 3-hydroxy-3-methyl-glutaryl-CoA reductase and reduces cholesterol levels in ApoE-/- mice.

Scharinger B, Messner B, Türkcan A, Schuster D, Vuorinen A, Pitterl F, Heinz K, Arnhard K, Laufer G, Grimm M, Stuppner H, Oberacher H, Eller P, Ritsch A, Bernhard D.

J Mol Cell Cardiol. 2016 Oct;99:35-46. doi: 10.1016/j.yjmcc.2016.08.003. Epub 2016 Aug 3.

11.

Cholesterol Efflux Capacity: Choke Point of Reverse Cholesterol Traffic?

März W, Ritsch A.

J Am Coll Cardiol. 2016 May 31;67(21):2488-91. doi: 10.1016/j.jacc.2016.04.005. No abstract available.

12.

The polyphenol PGG enhances expression of SR-BI and ABCA1 in J774 and THP-1 macrophages.

Zhao W, Haller V, Ritsch A.

Atherosclerosis. 2015 Oct;242(2):611-7. doi: 10.1016/j.atherosclerosis.2015.08.025. Epub 2015 Aug 20.

PMID:
26322417
13.

Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk.

Zewinger S, Drechsler C, Kleber ME, Dressel A, Riffel J, Triem S, Lehmann M, Kopecky C, Säemann MD, Lepper PM, Silbernagel G, Scharnagl H, Ritsch A, Thorand B, de las Heras Gala T, Wagenpfeil S, Koenig W, Peters A, Laufs U, Wanner C, Fliser D, Speer T, März W.

Eur Heart J. 2015 Nov 14;36(43):3007-16. doi: 10.1093/eurheartj/ehv352. Epub 2015 Aug 6.

PMID:
26248570
14.

HDL cholesterol efflux capacity and cardiovascular events.

Ritsch A, Scharnagl H, März W.

N Engl J Med. 2015 May 7;372(19):1870-1. doi: 10.1056/NEJMc1503139. No abstract available.

PMID:
25946300
15.

Fibrates ameliorate the course of bacterial sepsis by promoting neutrophil recruitment via CXCR2.

Tancevski I, Nairz M, Duwensee K, Auer K, Schroll A, Heim C, Feistritzer C, Hoefer J, Gerner RR, Moschen AR, Heller I, Pallweber P, Li X, Theurl M, Demetz E, Wolf AM, Wolf D, Eller P, Ritsch A, Weiss G.

EMBO Mol Med. 2014 Jun;6(6):810-20. doi: 10.1002/emmm.201303415. Epub 2014 Apr 6.

16.

Decreased cholesterol efflux capacity in patients with low cholesteryl ester transfer protein plasma levels.

Scharnagl H, Heuschneider C, Sailer S, Kleber ME, März W, Ritsch A.

Eur J Clin Invest. 2014 Apr;44(4):395-401. doi: 10.1111/eci.12248. Epub 2014 Feb 19.

PMID:
24467215
17.

High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality.

Silbernagel G, Schöttker B, Appelbaum S, Scharnagl H, Kleber ME, Grammer TB, Ritsch A, Mons U, Holleczek B, Goliasch G, Niessner A, Boehm BO, Schnabel RB, Brenner H, Blankenberg S, Landmesser U, März W.

Eur Heart J. 2013 Dec;34(46):3563-71. doi: 10.1093/eurheartj/eht343. Epub 2013 Sep 7.

18.

Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits.

Demetz E, Tancevski I, Duwensee K, Stanzl U, Huber E, Heim C, Handle F, Theurl M, Schroll A, Tailleux A, Dietrich H, Patsch JR, Eller P, Ritsch A.

Atherosclerosis. 2012 Jun;222(2):360-6. doi: 10.1016/j.atherosclerosis.2012.03.012. Epub 2012 Mar 23.

19.

Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein.

Duwensee K, Schwaiger S, Tancevski I, Eller K, van Eck M, Markt P, Linder T, Stanzl U, Ritsch A, Patsch JR, Schuster D, Stuppner H, Bernhard D, Eller P.

Atherosclerosis. 2011 Nov;219(1):109-15. doi: 10.1016/j.atherosclerosis.2011.07.023. Epub 2011 Jul 21.

20.

Ursolic acid causes DNA-damage, p53-mediated, mitochondria- and caspase-dependent human endothelial cell apoptosis, and accelerates atherosclerotic plaque formation in vivo.

Messner B, Zeller I, Ploner C, Frotschnig S, Ringer T, Steinacher-Nigisch A, Ritsch A, Laufer G, Huck C, Bernhard D.

Atherosclerosis. 2011 Dec;219(2):402-8. doi: 10.1016/j.atherosclerosis.2011.05.025. Epub 2011 Jun 23.

PMID:
21703625

Supplemental Content

Loading ...
Support Center